Procurement notices · Find a Tender + Contracts Finder

Notices

Every UK public-sector procurement notice in one board — open opportunities, closed tenders, awards, and pre-market signals. Filter by deadline, value or CPV, and save your search as an alert.

Closing 24h

Open notices

Closing this week

Don’t miss

Open · all

70,824

Live opportunities

Posted · 24h

244

New notices

Posted · 30d

10,693

All notice types

Awarded · 7d

1,301

Market signal

ActiveView: Awarded Clear all

465,981 noticesawarded · sorted by publication date

Page 51 of 23300

Time to close

Value

Type

Buyer

Notice

AWARDED

17 Jun

—

Awarded

Tender

FTS

Wilton Park

Electrical works

· Published 17 Jun

Notice peek

TenderFTS · 06a023

260129 - Contract for Supply, Delivery and Installation of Peptide Synthesizer and associated Maintenance, training, Ancillary Items and Consumables

Queen' University Belfast

Status

active

Awarded

—

Supplies

Published

22 May 2026

Key facts

Notice ID: ocds-h6vhtk-06a023
CPV code: 37315100 · Musical instruments
Contract type: Supplies
Source: Find a Tender

Timeline

Published
22 May 2026

Description

Queen’s University Belfast - The Future Medicines Institute (FMI) intends to procure a peptide synthesis solution comprising equipment, associated consumables, and appropriate maintenance and support arrangements to enable in house peptide synthesis capability. • Establishment of a reliable, in house peptide synthesis capability aligned to research delivery requirements. • Provision of supplier support, including training, to ensure competent and effective operation by authorised users. • Delivery of scalable synthesis capability to support routine generation of short peptides and time efficient synthesis of longer peptide sequences. • Enablement of consistent, reproducible outputs to meet ongoing and future research needs. The Future Medicines Institute (FMI) is focused on the identification and development of novel therapeutics and diagnostic approaches. The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics. The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation. This will facilitate collaborative research activity and enhance overall institutional research capability and impact.